Outcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents-Reference-Cited by-同舟云学术

Outcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents

Published:2007-05-09 Issue:18 Volume:297 Page:1992
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Beohar Nirat,Davidson Charles J.,Kip Kevin E.,Goodreau Lynne,Vlachos Helen Aslanidou,Meyers Sheridan N.,Benzuly Keith H.,Flaherty James D.,Ricciardi Mark J.,Bennett Charles L.,Williams David O.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing the new European Regulations on medical devices—clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology;European Heart Journal;2020-06-02

2. The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale;American Heart Journal;2019-10

3. Clinical outcomes and complications of treatment with supraflex stent in patients with coronary artery disease: One-year follow-up;European Journal of Translational Myology;2019-05-22

4. Disparities In The Use Of Drug-eluting Stents For Diabetic Patients With ST-elevation Acute Myocardial Infarction Assisted In the Public versus Private Network - VICTIM Register;Arquivos Brasileiros de Cardiologia;2019

5. Off-label Use of Medical Devices in Cardiovascular Medicine—When the Final Decision About the Safety and Effectiveness Is Needed;IFMBE Proceedings;2018-05-30